TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

PROTER

Pharmaceuticals
Generics

PROTER is a generic drug manufacturer with 2 FDA-approved products.

1964
Since
2
Drugs
-
Trials
8
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

TETRACYCLINE HYDROCHLORIDE 2025-03-31
Labeling
TETRACYCLINE HYDROCHLORIDE 2025-03-31
Labeling
OXYTETRACYCLINE HYDROCHLORIDE 2025-03-31
Labeling
TETRACYCLINE HYDROCHLORIDE 2025-03-31
Labeling
TETRACYCLINE HYDROCHLORIDE 2025-03-31
Labeling
TETRACYCLINE HYDROCHLORIDE 2025-03-20
Labeling
TETRACYCLINE HYDROCHLORIDE 2025-03-14
Labeling
TETRACYCLINE HYDROCHLORIDE 2025-03-14
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

No indication data

Pipeline Strength Pro

Loading...